Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Vertex Pharmaceuticals Shares Outstanding 2010-2024 | VRTX

Vertex Pharmaceuticals shares outstanding history from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Vertex Pharmaceuticals shares outstanding for the quarter ending September 30, 2024 were 0.261B, a 0.15% increase year-over-year.
  • Vertex Pharmaceuticals 2023 shares outstanding were 0.261B, a 0.54% increase from 2022.
  • Vertex Pharmaceuticals 2022 shares outstanding were 0.259B, a 0.31% decline from 2021.
  • Vertex Pharmaceuticals 2021 shares outstanding were 0.26B, a 1.33% decline from 2020.
  
Vertex Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2023 261
2022 259
2021 260
2020 263
2019 261
2018 259
2017 253
2016 245
2015 241
2014 235
2013 225
2012 215
2011 209
2010 200
2009 173
Vertex Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
2024-09-30 261
2024-06-30 258
2024-03-31 261
2023-12-31 261
2023-09-30 261
2023-06-30 260
2023-03-31 260
2022-12-31 259
2022-09-30 260
2022-06-30 259
2022-03-31 258
2021-12-31 260
2021-09-30 260
2021-06-30 261
2021-03-31 262
2020-12-31 263
2020-09-30 264
2020-06-30 263
2020-03-31 264
2019-12-31 261
2019-09-30 260
2019-06-30 260
2019-03-31 260
2018-12-31 259
2018-09-30 260
2018-06-30 259
2018-03-31 259
2017-12-31 253
2017-09-30 250
2017-06-30 252
2017-03-31 249
2016-12-31 245
2016-09-30 245
2016-06-30 244
2016-03-31 244
2015-12-31 241
2015-09-30 242
2015-06-30 241
2015-03-31 239
2014-12-31 235
2014-09-30 236
2014-06-30 234
2014-03-31 233
2013-12-31 225
2013-09-30 231
2013-06-30 222
2013-03-31 215
2012-12-31 215
2012-09-30 214
2012-06-30 211
2012-03-31 219
2011-12-31 209
2011-09-30 219
2011-06-30 204
2011-03-31 202
2010-12-31 200
2010-09-30 201
2010-06-30 200
2010-03-31 199
2009-12-31 173
2009-09-30 179
2009-06-30 173
2009-03-31 156
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $102.146B $9.869B
Vertex Pharmaceuticals Incorporated is focused on the discovery, development, and commercialization of small molecule drugs targeting serious diseases. The company's main area of focus is cystic fibrosis. The company's lead marketed products are Trikafta, Symdeko/Symkevi, Orkambi and Kalydeco, which are collectively approved to treat the people with CF in North America, Europe and Australia. Trikafta, Vertex's triple combination regimen, was approved by the FDA for the treatment of CF in people aged 12 years and older who have at least one F508del mutation. While CF remains the main area of focus, Vertex is also developing treatments for sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, type 1 diabetes, pain, alpha-1 antitrypsin deficiency and muscular dystrophies. Pimodivir/VX-787, for the treatment of influenza, was out-licensed to Janssen while oncology candidates VX-970, VX-984 and VX-803 were divested to Merck KGaA.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $140.398B 13.59
Bristol Myers Squibb (BMY) United States $114.186B 48.12
Gilead Sciences (GILD) United States $113.522B 20.56
CSL (CSLLY) Australia $83.739B 0.00
Regeneron Pharmaceuticals (REGN) United States $77.829B 17.72
GSK (GSK) United Kingdom $69.285B 8.02
Argenex SE (ARGX) Netherlands $37.792B 0.00
Alnylam Pharmaceuticals (ALNY) United States $30.810B 0.00
BioNTech SE (BNTX) Germany $26.468B 0.00
Biogen (BIIB) United States $21.478B 9.22
Illumina (ILMN) United States $21.252B 77.46
BeiGene (BGNE) Cayman Islands $17.031B 0.00
Moderna (MRNA) United States $15.223B 0.00
Genmab (GMAB) Denmark $13.295B 19.50
Incyte (INCY) United States $12.919B 0.00
Insmed (INSM) United States $12.418B 0.00
BioMarin Pharmaceutical (BMRN) United States $12.388B 28.76
Sarepta Therapeutics (SRPT) United States $11.412B 102.99
Bio-Techne Corp (TECH) United States $11.343B 43.80
Vaxcyte (PCVX) United States $10.745B 0.00
Exact Sciences (EXAS) United States $10.385B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $10.189B 42.09
QIAGEN (QGEN) Netherlands $10.114B 20.81
Exelixis (EXEL) United States $9.618B 21.87
Bio-Rad Laboratories (BIO.B) United States $9.123B 31.00
Intra-Cellular Therapies (ITCI) United States $8.920B 0.00
Roivant Sciences (ROIV) United Kingdom $8.371B 0.00
Ascendis Pharma (ASND) Denmark $8.353B 0.00
Repligen (RGEN) United States $8.210B 106.96
Jazz Pharmaceuticals (JAZZ) Ireland $7.427B 7.26
Revolution Medicines (RVMD) United States $7.282B 0.00
Legend Biotech (LEGN) United States $6.213B 0.00
Halozyme Therapeutics (HALO) United States $6.020B 13.60
Nuvalent (NUVL) United States $6.014B 0.00
Blueprint Medicines (BPMC) United States $5.649B 0.00
Cytokinetics (CYTK) United States $5.516B 0.00
Telix Pharmaceuticals (TLX) Australia $5.469B 0.00
Alkermes (ALKS) Ireland $4.849B 16.29
TG Therapeutics (TGTX) United States $4.818B 0.00
Krystal Biotech (KRYS) United States $4.626B 76.59
Viking Therapeutics (VKTX) United States $4.624B 0.00
Axsome Therapeutics (AXSM) United States $4.349B 0.00
ADMA Biologics Inc (ADMA) United States $4.231B 44.75
Apellis Pharmaceuticals (APLS) United States $4.122B 0.00
Arcellx (ACLX) United States $4.067B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.014B 0.00
Scholar Rock Holding (SRRK) United States $3.940B 0.00
Guardant Health (GH) United States $3.846B 0.00
Immunovant (IMVT) United States $3.766B 0.00
Avidity Biosciences (RNA) United States $3.705B 0.00
Alvotech (ALVO) Luxembourg $3.651B 0.00
Biohaven (BHVN) United States $3.574B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.447B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.410B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $3.349B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.315B 0.00
NovoCure (NVCR) Jersey $3.289B 0.00
Denali Therapeutics (DNLI) United States $3.093B 0.00
Janux Therapeutics (JANX) United States $2.978B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.966B 0.00
Edgewise Therapeutics (EWTX) United States $2.916B 0.00
Amicus Therapeutics (FOLD) United States $2.907B 0.00
Merus (MRUS) Netherlands $2.882B 0.00
Zai Lab (ZLAB) China $2.848B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.784B 21.45
Vericel (VCEL) United States $2.712B 915.83
Vera Therapeutics (VERA) United States $2.663B 0.00
Twist Bioscience (TWST) United States $2.589B 0.00
SpringWorks Therapeutics (SWTX) United States $2.587B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.547B 0.00
Kymera Therapeutics (KYMR) United States $2.535B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.426B 0.00
Protagonist Therapeutics (PTGX) United States $2.357B 14.86
Beam Therapeutics (BEAM) United States $2.223B 0.00
Geron (GERN) United States $2.212B 0.00
Iovance Biotherapeutics (IOVA) United States $2.201B 0.00
Ligand Pharmaceuticals (LGND) United States $2.153B 53.75
IDEAYA Biosciences (IDYA) United States $2.143B 0.00
CG Oncology (CGON) United States $2.131B 0.00
Apogee Therapeutics (APGE) United States $2.117B 0.00
NeoGenomics (NEO) United States $2.105B 0.00
Bavarian Nordic (BVNRY) Denmark $2.091B 12.81
Agios Pharmaceuticals (AGIO) United States $2.042B 0.00
WAVE Life Sciences (WVE) Singapore $2.012B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.988B 0.00
Akero Therapeutics (AKRO) United States $1.982B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.974B 0.00
Belite Bio (BLTE) United States $1.942B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.933B 16.06
Mesoblast (MESO) Australia $1.914B 0.00
Disc Medicine (IRON) United States $1.873B 0.00
ImmunityBio (IBRX) United States $1.861B 0.00
Galapagos (GLPG) Belgium $1.738B 0.00
MannKind (MNKD) United States $1.737B 45.00
Structure Therapeutics (GPCR) United States $1.716B 0.00
Certara (CERT) United States $1.698B 47.96
Neumora Therapeutics (NMRA) United States $1.696B 0.00
Celldex Therapeutics (CLDX) United States $1.684B 0.00
Dynavax Technologies (DVAX) United States $1.677B 98.15
Fortrea Holdings (FTRE) United States $1.659B 52.86
Arcutis Biotherapeutics (ARQT) United States $1.652B 0.00
Viridian Therapeutics (VRDN) United States $1.484B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.479B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.422B 0.00
Nurix Therapeutics (NRIX) United States $1.420B 0.00
Arcus Biosciences (RCUS) United States $1.415B 0.00
Novavax (NVAX) United States $1.390B 0.00
Travere Therapeutics (TVTX) United States $1.358B 0.00
Praxis Precision Medicines (PRAX) United States $1.358B 0.00
MiMedx (MDXG) United States $1.334B 34.92
Day One Biopharmaceuticals (DAWN) United States $1.257B 0.00
Intellia Therapeutics (NTLA) United States $1.230B 0.00
Arvinas (ARVN) United States $1.225B 0.00
Myriad Genetics (MYGN) United States $1.199B 0.00
Spyre Therapeutics (SYRE) United States $1.190B 0.00
ANI Pharmaceuticals (ANIP) United States $1.141B 15.55
Syndax Pharmaceuticals (SNDX) United States $1.097B 0.00
Septerna (SEPN) United States $1.039B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.036B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.035B 0.00
Vir Biotechnology (VIR) United States $1.015B 0.00
Gyre Therapeutics (GYRE) United States $0.997B 0.00
Zymeworks (ZYME) United States $0.935B 0.00
Poseida Therapeutics (PSTX) United States $0.920B 0.00
Nuvation Bio (NUVB) United States $0.905B 0.00
Pacira BioSciences (PCRX) United States $0.904B 8.51
Bicara Therapeutics (BCAX) United States $0.903B 0.00
Liquidia Technologies (LQDA) United States $0.896B 0.00
Upstream Bio (UPB) United States $0.890B 0.00
Adaptive Biotechnologies (ADPT) United States $0.885B 0.00
ArriVent BioPharma (AVBP) United States $0.864B 0.00
Cogent Biosciences (COGT) United States $0.862B 0.00
Prothena (PRTA) Ireland $0.861B 0.00
LENZ Therapeutics (LENZ) United States $0.833B 0.00
Replimune (REPL) United States $0.822B 0.00
Immatics (IMTX) Germany $0.821B 0.00
Pliant Therapeutics (PLRX) United States $0.809B 0.00
AbCellera Biologics (ABCL) Canada $0.800B 0.00
Cytek Biosciences (CTKB) United States $0.797B 0.00
Avid Bioservices (CDMO) United States $0.789B 0.00
Castle Biosciences (CSTL) United States $0.759B 135.45
UniQure (QURE) Netherlands $0.754B 0.00
89BIO (ETNB) United States $0.746B 0.00
Tyra Biosciences (TYRA) United States $0.734B 0.00
Anavex Life Sciences (AVXL) United States $0.718B 0.00
Kura Oncology (KURA) United States $0.698B 0.00
Erasca (ERAS) United States $0.693B 0.00
Immunome (IMNM) United States $0.692B 0.00
Oculis Holding AG (OCS) Switzerland $0.689B 0.00
Keros Therapeutics (KROS) United States $0.685B 0.00
Dianthus Therapeutics (DNTH) United States $0.682B 0.00
MBX Biosciences (MBX) United States $0.677B 0.00
CureVac (CVAC) Germany $0.669B 5.44
Rapport Therapeutics (RAPP) United States $0.653B 0.00
Tectonic Therapeutic (TECX) United States $0.650B 0.00
Entrada Therapeutics (TRDA) United States $0.647B 10.87
Sinovac Biotech (SVA) China $0.645B 0.00
Cullinan Therapeutics (CGEM) United States $0.638B 0.00
CARGO Therapeutics (CRGX) United States $0.622B 0.00
Arbutus Biopharma (ABUS) United States $0.608B 0.00
Pharming Group (PHAR) Netherlands $0.606B 0.00
Stoke Therapeutics (STOK) United States $0.599B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.596B 0.00
Mineralys Therapeutics (MLYS) United States $0.589B 0.00
GRAIL (GRAL) United States $0.576B 0.00
Annexon (ANNX) United States $0.556B 0.00
Oric Pharmaceuticals (ORIC) United States $0.543B 0.00
CorMedix Inc (CRMD) United States $0.538B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.535B 0.00
Astria Therapeutics (ATXS) United States $0.533B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.514B 0.00
Terns Pharmaceuticals (TERN) United States $0.514B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.510B 0.00
PureTech Health (PRTC) United States $0.505B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.502B 0.00
Abivax SA (ABVX) France $0.492B 0.00
Third Harmonic Bio (THRD) United States $0.490B 0.00
Cartesian Therapeutics (RNAC) United States $0.490B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.486B 0.00
Sangamo Therapeutics (SGMO) United States $0.482B 0.00
Kodiak Sciences (KOD) United States $0.457B 0.00
AnaptysBio (ANAB) United States $0.456B 0.00
MeiraGTx Holdings (MGTX) United States $0.456B 0.00
Celcuity (CELC) United States $0.446B 0.00
MaxCyte (MXCT) United States $0.438B 0.00
Emergent Biosolutions (EBS) United States $0.437B 0.00
Humacyte (HUMA) United States $0.435B 0.00
IGM Biosciences (IGMS) United States $0.419B 0.00
Codexis (CDXS) United States $0.417B 0.00
ChromaDex (CDXC) United States $0.413B 541.00
Zenas BioPharma (ZBIO) United States $0.408B 0.00
Alumis (ALMS) United States $0.408B 0.00
Aura Biosciences (AURA) United States $0.405B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.402B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.400B 0.00
Alpha Teknova (TKNO) United States $0.386B 0.00
Allogene Therapeutics (ALLO) United States $0.386B 0.00
GH Research (GHRS) Ireland $0.384B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.384B 0.00
REGENXBIO (RGNX) United States $0.367B 0.00
Prime Medicine (PRME) United States $0.366B 0.00
Sana Biotechnology (SANA) United States $0.357B 0.00
Contineum Therapeutics (CTNM) United States $0.344B 0.00
Northwest Biotherapeutics (NWBO) United States $0.341B 0.00
Design Therapeutics (DSGN) United States $0.339B 0.00
Kamada (KMDA) Israel $0.336B 20.89
Absci (ABSI) United States $0.335B 0.00
Olema Pharmaceuticals (OLMA) United States $0.332B 0.00
Neurogene (NGNE) United States $0.328B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.327B 0.00
Candel Therapeutics (CADL) United States $0.323B 0.00
ACELYRIN, INC (SLRN) United States $0.323B 0.00
Jasper Therapeutics (JSPR) United States $0.323B 0.00
Revance Therapeutics (RVNC) United States $0.320B 0.00
Eton Pharmaceuticals (ETON) United States $0.320B 0.00
Trevi Therapeutics (TRVI) United States $0.319B 0.00
Tango Therapeutics (TNGX) United States $0.316B 0.00
Voyager Therapeutics (VYGR) United States $0.311B 8.01
Prima BioMed (IMMP) Australia $0.308B 0.00
Sage Therapeutics (SAGE) United States $0.306B 0.00
XOMA Royalty (XOMA) United States $0.296B 0.00
Benitec Biopharma (BNTC) United States $0.283B 0.00
Foghorn Therapeutics (FHTX) United States $0.277B 0.00
C4 Therapeutics (CCCC) United States $0.271B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.270B 0.00
AC Immune (ACIU) Switzerland $0.267B 0.00
ATyr Pharma (ATYR) United States $0.264B 0.00
Atea Pharmaceuticals (AVIR) United States $0.264B 0.00
ITeos Therapeutics (ITOS) United States $0.264B 0.00
EnGene Holdings (ENGN) Canada $0.264B 0.00
Lifecore Biomedical (LFCR) United States $0.260B 0.00
BioStem Technologies (BSEM) $0.256B 22.68
Chimerix (CMRX) United States $0.256B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.252B 0.00
Urogen Pharma (URGN) United States $0.251B 0.00
Renovaro (RENB) United States $0.245B 0.00
Rezolute (RZLT) United States $0.245B 0.00
Abeona Therapeutics (ABEO) United States $0.245B 0.00
Artiva Biotherapeutics (ARTV) United States $0.243B 0.00
Anika Therapeutics (ANIK) United States $0.239B 0.00
Cardiff Oncology (CRDF) United States $0.230B 0.00
Nautilus Biotechnology (NAUT) United States $0.226B 0.00
Ocugen (OCGN) United States $0.224B 0.00
Fulcrum Therapeutics (FULC) United States $0.217B 0.00
Mersana Therapeutics (MRSN) United States $0.215B 0.00
Precigen (PGEN) United States $0.213B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.212B 0.00
Molecular Partners AG (MOLN) Switzerland $0.211B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.209B 0.00
DiaMedica Therapeutics (DMAC) United States $0.208B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.205B 0.00
Inhibrx Biosciences (INBX) United States $0.201B 0.00
Verastem (VSTM) United States $0.198B 0.00
XBiotech (XBIT) United States $0.193B 0.00
Amarin (AMRN) Ireland $0.191B 0.00
Gossamer Bio (GOSS) United States $0.191B 0.00
Fate Therapeutics (FATE) United States $0.189B 0.00
Opthea (OPT) Australia $0.189B 0.00
Compass Therapeutics (CMPX) United States $0.189B 0.00
GENFIT S.A (GNFT) France $0.186B 0.00
BioAge Labs (BIOA) United States $0.185B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.182B 0.00
Inozyme Pharma (INZY) United States $0.181B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.178B 0.00
Innate Pharma S.A (IPHA) France $0.175B 0.00
Alector (ALEC) United States $0.174B 0.00
Bright Minds Biosciences (DRUG) United States $0.173B 0.00
Coherus BioSciences (CHRS) United States $0.171B 0.00
TuHURA Biosciences (HURA) United States $0.169B 0.00
Semper Paratus Acquisition (TVGN) United States $0.169B 0.00
Kyverna Therapeutics (KYTX) United States $0.167B 0.00
ScPharmaceuticals (SCPH) United States $0.166B 0.00
Checkpoint Therapeutics (CKPT) United States $0.165B 0.00
Greenwich LifeSciences (GLSI) United States $0.165B 0.00
Caribou Biosciences (CRBU) United States $0.164B 0.00
Ventyx Biosciences (VTYX) United States $0.161B 0.00
Adherex Technologies (FENC) United States $0.160B 0.00
Solid Biosciences (SLDB) United States $0.160B 0.00
Cidara Therapeutics (CDTX) United States $0.159B 0.00
Seres Therapeutics (MCRB) United States $0.157B 0.00
TScan Therapeutics (TCRX) United States $0.156B 0.00
Sagimet Biosciences (SGMT) United States $0.156B 0.00
Nkarta (NKTX) United States $0.155B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.154B 0.00
Zura Bio (ZURA) United States $0.153B 0.00
2seventy Bio (TSVT) United States $0.151B 0.00
Sutro Biopharma (STRO) United States $0.150B 0.00
Biomea Fusion (BMEA) United States $0.148B 0.00
Actuate Therapeutics (ACTU) United States $0.138B 0.00
Aligos Therapeutics (ALGS) United States $0.138B 0.00
Seer (SEER) United States $0.137B 0.00
Puma Biotechnology (PBYI) United States $0.136B 5.79
Compugen (CGEN) Israel $0.136B 76.00
PepGen (PEPG) United States $0.133B 0.00
Climb Bio (CLYM) United States $0.131B 0.00
Instil Bio (TIL) United States $0.131B 0.00
Akoya Biosciences (AKYA) United States $0.126B 0.00
Monopar Therapeutics (MNPR) United States $0.126B 0.00
InflaRx (IFRX) Germany $0.125B 0.00
Inventiva S.A (IVA) France $0.124B 0.00
Black Diamond Therapeutics (BDTX) United States $0.124B 0.00
Elutia (ELUT) United States $0.122B 0.00
Applied Therapeutics (APLT) United States $0.119B 0.00
Invizyne Technologies (IZTC) United States $0.118B 0.00
Allakos (ALLK) United States $0.115B 0.00
Cabaletta Bio (CABA) United States $0.113B 0.00
Tenaya Therapeutics (TNYA) United States $0.112B 0.00
Editas Medicine (EDIT) United States $0.111B 0.00
TELA Bio (TELA) United States $0.110B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.108B 0.00
CAMP4 Therapeutics (CAMP) United States $0.108B 0.00
Leap Therapeutics (LPTX) United States $0.107B 0.00
MediciNova (MNOV) United States $0.106B 0.00
X4 Pharmaceuticals (XFOR) United States $0.104B 0.00
BioHarvest Sciences (BHST) Canada $0.102B 0.00
Alto Neuroscience (ANRO) United States $0.100B 0.00
Genenta Science S.p.A (GNTA) Italy $0.098B 0.00
INmune Bio (INMB) United States $0.098B 0.00
Adverum Biotechnologies (ADVM) United States $0.098B 0.00
Immunic (IMUX) United States $0.094B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.091B 0.00
HilleVax (HLVX) United States $0.091B 0.00
Nuvectis Pharma (NVCT) United States $0.091B 0.00
Bluebird Bio (BLUE) United States $0.090B 0.00
Adagene (ADAG) China $0.089B 0.00
Cellectis S.A (CLLS) France $0.088B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.088B 0.00
Skye Bioscience (SKYE) United States $0.087B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.087B 0.00
Coya Therapeutics (COYA) United States $0.086B 0.00
CytomX Therapeutics (CTMX) United States $0.086B 6.47
Scilex Holding (SCLX) United States $0.084B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.082B 0.00
23andMe Holding (ME) United States $0.080B 0.00
Adlai Nortye (ANL) Cayman Islands $0.079B 0.00
ALX Oncology Holdings (ALXO) United States $0.078B 0.00
Ikena Oncology (IKNA) United States $0.078B 0.00
I-Mab (IMAB) China $0.078B 0.00
Alpha Cognition (ACOG) Canada $0.078B 0.00
Quince Therapeutics (QNCX) United States $0.077B 0.00
Entera Bio (ENTX) Israel $0.077B 0.00
Abpro Holdings (ABP) United States $0.077B 0.00
Theratechnologies (THTX) Canada $0.076B 0.00
Genelux (GNLX) United States $0.076B 0.00
Rani Therapeutics Holdings (RANI) United States $0.074B 0.00
Aerovate Therapeutics (AVTE) United States $0.073B 0.00
Ovid Therapeutics (OVID) United States $0.072B 0.00
Generation Bio (GBIO) United States $0.072B 0.00
Adicet Bio (ACET) United States $0.071B 0.00
Clearside Biomedical (CLSD) United States $0.071B 0.00
FibroBiologics (FBLG) United States $0.070B 0.00
Werewolf Therapeutics (HOWL) United States $0.070B 0.00
Oncolytics Biotech (ONCY) Canada $0.068B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.068B 0.00
Vigil Neuroscience (VIGL) United States $0.068B 0.00
ZIVO Bioscience (ZIVO) United States $0.067B 0.00
PDS Biotechnology (PDSB) United States $0.065B 0.00
Agenus (AGEN) United States $0.065B 0.00
Cue Biopharma (CUE) United States $0.065B 0.00
Galena Biopharma (SLS) United States $0.063B 0.00
DBV Technologies S.A (DBVT) France $0.063B 0.00
VistaGen Therapeutics (VTGN) United States $0.063B 0.00
BGM Group (BGM) China $0.061B 0.00
Immix Biopharma (IMMX) United States $0.061B 0.00
Vor Biopharma (VOR) $0.061B 0.00
Annovis Bio (ANVS) United States $0.061B 0.00
BeyondSpring (BYSI) United States $0.060B 0.00
BioAtla (BCAB) United States $0.058B 0.00
Atara Biotherapeutics (ATRA) United States $0.057B 0.00
Aadi Bioscience (AADI) United States $0.057B 0.00
Immuneering (IMRX) United States $0.057B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.057B 0.00
Dyadic (DYAI) United States $0.056B 0.00
Boundless Bio (BOLD) United States $0.056B 0.00
Repare Therapeutics (RPTX) Canada $0.056B 0.00
Kronos Bio (KRON) United States $0.056B 0.00
Connect Biopharma Holdings (CNTB) United States $0.055B 0.00
Elicio Therapeutics (ELTX) United States $0.055B 0.00
Spero Therapeutics (SPRO) United States $0.054B 14.26
Invivyd (IVVD) United States $0.051B 0.00
IO Biotech (IOBT) Denmark $0.050B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.050B 0.00
Shattuck Labs (STTK) United States $0.050B 0.00
Celularity (CELU) United States $0.049B 0.00
Inovio Pharmaceuticals (INO) United States $0.048B 0.00
Fortress Biotech (FBIO) United States $0.048B 0.00
Kezar Life Sciences (KZR) United States $0.048B 0.00
VTv Therapeutics (VTVT) United States $0.046B 0.00
Omega Therapeutics (OMGA) United States $0.045B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.042B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.041B 0.00
Xilio Therapeutics (XLO) United States $0.041B 0.00
Grace Therapeutics (GRCE) Canada $0.041B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.041B 0.00
Exicure (XCUR) United States $0.041B 0.00
Q32 Bio (QTTB) United States $0.041B 0.00
Rallybio (RLYB) United States $0.041B 0.00
Passage Bio (PASG) United States $0.040B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.040B 0.00
Estrella Immunopharma (ESLA) United States $0.040B 0.00
Lexaria Bioscience (LEXX) Canada $0.039B 0.00
Aileron Therapeutics (ALRN) United States $0.038B 0.00
AN2 Therapeutics (ANTX) United States $0.038B 0.00
CalciMedica (CALC) United States $0.037B 0.00
Enzo Biochem (ENZ) United States $0.037B 0.00
Elevation Oncology (ELEV) United States $0.037B 0.00
OKYO Pharma (OKYO) $0.037B 0.00
SAB Biotherapeutics (SABS) United States $0.036B 0.00
Clene (CLNN) United States $0.036B 0.00
Precision BioSciences (DTIL) United States $0.035B 0.00
Lantern Pharma (LTRN) United States $0.035B 0.00
Oncobiologics (OTLK) United States $0.033B 0.00
Opus Genetics (IRD) United States $0.031B 0.00
Intensity Therapeutics (INTS) United States $0.030B 0.00
Beyond Air (XAIR) United States $0.030B 0.00
Promis Neurosciences (PMN) Canada $0.030B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.029B 0.00
Rapt Therapeutics (RAPT) United States $0.028B 0.00
KALA BIO (KALA) United States $0.028B 0.00
RenovoRx (RNXT) United States $0.028B 0.00
Forte Biosciences (FBRX) United States $0.027B 0.00
OnKure Therapeutics (OKUR) United States $0.027B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.027B 0.00
NextCure (NXTC) United States $0.027B 0.00
Medicus Pharma (MDCX) Canada $0.027B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.026B 0.00
Cognition Therapeutics (CGTX) United States $0.026B 0.00
Curis (CRIS) United States $0.026B 0.00
Dare Bioscience (DARE) United States $0.026B 0.00
BRIACELL THERAP (BCTX) Canada $0.026B 0.00
HOOKIPA Pharma (HOOK) United States $0.026B 0.00
Gelteq (GELS) Australia $0.026B 0.00
Femasys (FEMY) United States $0.025B 0.00
LakeShore Biopharma (LSB) China $0.025B 0.00
Pluri (PLUR) Israel $0.024B 0.00
Cadrenal Therapeutics (CVKD) United States $0.024B 0.00
Longeveron (LGVN) United States $0.024B 0.00
Chemomab Therapeutics (CMMB) Israel $0.023B 0.00
Cara Therapeutics (CARA) United States $0.022B 0.00
GeoVax Labs (GOVX) United States $0.022B 0.00
Pulmatrix (PULM) United States $0.022B 0.00
Cocrystal Pharma (COCP) United States $0.021B 0.00
Equillium (EQ) United States $0.021B 0.00
Athira Pharma (ATHA) United States $0.021B 0.00
Lisata Therapeutics (LSTA) United States $0.021B 0.00
Ocean Biomedical (OCEA) United States $0.021B 0.00
Bionano Genomics (BNGO) United States $0.020B 0.00
NKGen Biotech (NKGN) United States $0.020B 0.00
MiNK Therapeutics (INKT) United States $0.020B 0.00
Bolt Biotherapeutics (BOLT) United States $0.019B 0.00
Affimed (AFMD) Germany $0.019B 0.00
Tenax Therapeutics (TENX) United States $0.019B 0.00
BioAffinity Technologies (BIAF) United States $0.018B 0.00
Senti Biosciences (SNTI) United States $0.018B 0.00
Cyclo Therapeutics (CYTH) United States $0.018B 0.00
Aprea Therapeutics (APRE) United States $0.018B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.017B 0.00
IN8bio (INAB) United States $0.017B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.017B 0.00
UNITY Biotechnology (UBX) United States $0.016B 0.00
Synlogic (SYBX) United States $0.016B 0.00
Spruce Biosciences (SPRB) United States $0.016B 0.00
HCW Biologics (HCWB) United States $0.016B 0.00
Prana Biotechnology (ATHE) Australia $0.015B 0.00
MetaVia (MTVA) United States $0.015B 0.00
CervoMed (CRVO) United States $0.014B 0.00
BioXcel Therapeutics (BTAI) United States $0.013B 0.00
Novogen (KZIA) Australia $0.013B 0.00
Cingulate (CING) United States $0.013B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.013B 0.00
Imunon (IMNN) United States $0.012B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Sensei Biotherapeutics (SNSE) United States $0.011B 0.00
Turnstone Biologics (TSBX) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Ensysce Biosciences (ENSC) United States $0.010B 0.00
Aptose Biosciences (APTO) Canada $0.010B 0.00
Apollomics (APLM) United States $0.010B 0.00
Biorestorative Therapies (BRTX) United States $0.010B 0.00
Polyrizon (PLRZ) Israel $0.010B 0.00
Mainz Biomed (MYNZ) Germany $0.010B 0.00
Aytu BioPharma (AYTU) United States $0.008B 0.00
BioCardia (BCDA) United States $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
Mustang Bio (MBIO) United States $0.008B 0.00
Eyenovia (EYEN) United States $0.008B 0.00
Soligenix (SNGX) United States $0.008B 0.00
GENPREX (GNPX) United States $0.008B 0.00
Vincerx Pharma (VINC) United States $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
GRI Bio (GRI) United States $0.007B 0.00
Alzamend Neuro (ALZN) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
Quantum Biopharma (QNTM) Canada $0.007B 0.00
CNS Pharmaceuticals (CNSP) United States $0.006B 0.00
Galecto (GLTO) Denmark $0.006B 0.00
Portage Biotech (PRTG) $0.006B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.006B 0.00
Elevai Labs (ELAB) United States $0.006B 0.00
Edesa Biotech (EDSA) Canada $0.006B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.006B 0.00
Moleculin Biotech (MBRX) United States $0.006B 0.00
Organovo Holdings (ONVO) United States $0.006B 0.00
Syros Pharmaceuticals (SYRS) United States $0.005B 0.00
Hoth Therapeutics (HOTH) United States $0.005B 0.00
Evaxion Biotech (EVAX) Denmark $0.005B 0.00
Carmell (CTCX) United States $0.005B 0.00
Purple Biotech (PPBT) Israel $0.005B 0.00
Allarity Therapeutics (ALLR) United States $0.005B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
Bionomics (BNOX) Australia $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
GT Biopharma (GTBP) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.004B 0.00
Silo Pharma (SILO) United States $0.004B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.004B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.003B 0.00
Sunshine Biopharma (SBFM) United States $0.003B 0.00
NAYA Biosciences (NAYA) United States $0.003B 0.00
Pasithea Therapeutics (KTTA) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
NuCana (NCNA) United Kingdom $0.003B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
Dogwood Therapeutics (DWTX) United States $0.003B 0.00
Artelo Biosciences (ARTL) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Titan Pharmaceuticals (TTNP) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Citius Oncology (CTOR) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Psyence Biomedical (PBM) Canada $0.002B 0.00
AquaBounty Technologies (AQB) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.002B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
Eterna Therapeutics (ERNA) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.000B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuBase Therapeutics (NBSE) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00